US Consumer Health Regulation: Before Warning, Recall For Supplement With COVID-19 Label Claim

Until FDA on 23 June posted report about Golden Nutrition Inc.’s herbal supplement, violative COVID-19 claims had been found online and in advertising through other channels. Other consumer health recalls in US include more than 2.5m bottles of Gaviscon Liquid Antacid missing a safety warning on labels.

Attention Please_1014394012_1200.jpg

Posting unlawful claims online for treating or preventing COVID-19 will prompt regulatory warnings in the US, but using those claims on product labels will lead to a recall, as a Florida firm learned recently.

Additional consumer health products on recall in the US include more than 2

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Recalls

More from Policy & Regulation